Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARING: Aspirin Chronotherapy for CV Prevention
NCT00725127Phase 4Active, not recruiting
- Sponsor
- Universidade de Vigo
- Start
- Oct 2008
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in cardiovascular diseases (CVD), cerebrovascular disease, chronic kidney disease (CKD), sponsored by Universidade de Vigo. Started Oct 2008; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)cerebrovascular diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00725127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725127.